Article Details

Therapeutics Acquisition : POINT Biopharma Announces First Patients Dosed in Phase 3 Study of ...

Retrieved on: 2021-06-04 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

Therapeutics Acquisition : POINT Biopharma Announces First Patients Dosed in Phase 3 Study of .... View article details on hiswai:

Excerpt

POINT Biopharma has entered into a definitive merger agreement with Research Alliance Corp. I (Nasdaq: RACA). Upon closing, the combined ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up